Literature DB >> 2317944

Depressed lymphocyte transformation and the role of prostaglandins in atopic dermatitis.

T Jakob1, B N Huspith, Y E Latchman, R Rycroft, J Brostoff.   

Abstract

We have shown that peripheral blood mononuclear cells (PBMC) from patients with atopic dermatitis have a reduced in vitro proliferative responsiveness to concanavalin A when compared with non-atopic controls. Addition of the cyclo-oxygenase inhibitor indomethacin caused a significant enhancement of the mitogen response in the patients, indicating a suppressive effect of cyclooxygenase products. We have further demonstrated increased levels of prostaglandin E2 in the supernatants of the PBMC cultures and increased levels of IgE immune complexes in the sera of the atopic dermatitis patients and therefore hypothesize that IgE immune complexes may cause increased monocyte production of prostaglandins which in turn appears to be responsible for a reduced lymphocyte proliferation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2317944      PMCID: PMC1534959          DOI: 10.1111/j.1365-2249.1990.tb08099.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  Complement and immunoglobulin deposits in the skin of patients with atopic dermatitis.

Authors:  J Ring; T Senter; R C Cornell; C M Arroyave; E M Tan
Journal:  Br J Dermatol       Date:  1978-11       Impact factor: 9.302

2.  Suppressed cell-mediated immunity in two adults with atopic dermatitis.

Authors:  W C Lobitz; J F Honeyman; N W Winkler
Journal:  Br J Dermatol       Date:  1972-04       Impact factor: 9.302

3.  Lymphocyte response to phytohemagglutinin in atopic dermatitis.

Authors:  S T Elliott; J M Hanifin
Journal:  Arch Dermatol       Date:  1979-12

Review 4.  Newer concepts of atopic dermatitis.

Authors:  J M Hanifin; W C Lobitz
Journal:  Arch Dermatol       Date:  1977-05

Review 5.  Regulation of the immune response by prostaglandins.

Authors:  J S Goodwin; D R Webb
Journal:  Clin Immunol Immunopathol       Date:  1980-01

6.  Immunodeficiencies in severe atopic dermatitis. Depressed chemotaxis and lymphocyte transformation.

Authors:  J L Rogge; J M Hanifin
Journal:  Arch Dermatol       Date:  1976-10

7.  Depression of cell-mediated immunity in atopic eczema.

Authors:  S J McGeady; R H Buckley
Journal:  J Allergy Clin Immunol       Date:  1975-11       Impact factor: 10.793

8.  Associated expression of CD1 antigen and Fc receptor for IgE on epidermal Langerhans cells from patients with atopic dermatitis.

Authors:  C Bruynzeel-Koomen; E M van der Donk; P L Bruynzeel; M Capron; G C de Gast; G C Mudde
Journal:  Clin Exp Immunol       Date:  1988-10       Impact factor: 4.330

9.  Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell.

Authors:  J S Goodwin; A D Bankhurst; R P Messner
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

10.  Prostaglandin E production by human blood monocytes and mouse peritoneal macrophages.

Authors:  J I Kurland; R Bockman
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

View more
  8 in total

1.  Knockdown of sodium channel Nax reduces dermatitis symptoms in rabbit skin.

Authors:  Jingling Zhao; Shengxian Jia; Ping Xie; Emily Friedrich; Robert D Galiano; Shaohai Qi; Renxiang Mao; Thomas A Mustoe; Seok Jong Hong
Journal:  Lab Invest       Date:  2020-01-10       Impact factor: 5.662

2.  Differential regulation of IFN-gamma, IL-10 and inducible nitric oxide synthase in human T cells by cyclic AMP-dependent signal transduction pathway.

Authors:  N Benbernou; S Esnault; H C Shin; H Fekkar; M Guenounou
Journal:  Immunology       Date:  1997-07       Impact factor: 7.397

3.  A type 2 response in lipopolysaccharide (LPS)-stimulated whole blood cell cultures from periodontitis patients.

Authors:  S J Fokkema; B G Loos; C Slegte; U van der Velden
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

4.  Enhanced prostaglandin E2 production by monocytes in atopic dermatitis (AD) is not accompanied by enhanced production of IL-6, IL-10 or IL-12.

Authors:  A Snijders; T C Van der Pouw Kraan; M Engel; J Wormmeester; P Widjaja; I M Zonneveld; J D Bos; M L Kapsenberg
Journal:  Clin Exp Immunol       Date:  1998-03       Impact factor: 4.330

5.  cAMP activates the generation of reactive oxygen species and inhibits the secretion of IL-6 in peripheral blood mononuclear cells from type 2 diabetic patients.

Authors:  Camila Armond Isoni; Erica Abreu Borges; Clara Araújo Veloso; Rafael Teixeira Mattos; Miriam Martins Chaves; José Augusto Nogueira-Machado
Journal:  Oxid Med Cell Longev       Date:  2009 Nov-Dec       Impact factor: 6.543

6.  Histamine inhibits the production of interleukin-12 through interaction with H2 receptors.

Authors:  T C van der Pouw Kraan; A Snijders; L C Boeije; E R de Groot; A E Alewijnse; R Leurs; L A Aarden
Journal:  J Clin Invest       Date:  1998-11-15       Impact factor: 14.808

7.  Augmentation of antigen-specific lymphoproliferative responses in vitro by biological response modifiers.

Authors:  T D de Gruijl; J J Moore; E de Vries; B M von Blomberg-van der Flier; J C Fonk; R J Scheper
Journal:  Clin Exp Immunol       Date:  1994-06       Impact factor: 4.330

8.  Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production.

Authors:  T C van der Pouw Kraan; L C Boeije; R J Smeenk; J Wijdenes; L A Aarden
Journal:  J Exp Med       Date:  1995-02-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.